Gastrointestinal symptoms in COVID-19
Konrad Lewandowski1, Magdalena Kaniewska1, Mariusz Rosołowski2,3
1Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of Ministry of Inferior and Administration, Warsaw, Poland.
COVID-19 affects the respiratory and digestive systems. This review examines meta-analyses on gastrointestinal symptoms and gut microbiome disturbances in SARS-CoV-2 infection.
Area of Science:
- Gastroenterology
- Virology
- Microbiology
Background:
- SARS-CoV-2 primarily impacts the respiratory system.
- Gastrointestinal symptoms are common in COVID-19, indicating digestive system involvement.
- The pathogenesis of these abdominal symptoms is multifaceted.
Purpose of the Study:
- To provide an overview of key meta-analyses and publications.
- To explore the relationship between COVID-19, gastrointestinal symptoms, and the gut microbiome.
- To summarize current understanding of the gut's role in SARS-CoV-2.
Main Methods:
- Literature review of meta-analyses and publications.
- Synthesis of data on gastrointestinal manifestations of COVID-19.
- Analysis of studies investigating gut microbiome alterations.
Main Results:
- The digestive system is significantly involved in COVID-19 expression and pathogenesis.
- Potential mechanisms include angiotensin 2 receptor interactions and cytokine storms.
- Disturbances in the gut microbiome are frequently observed in COVID-19 patients.
Conclusions:
- COVID-19 has a notable impact on the gastrointestinal tract.
- Understanding gut microbiome changes is crucial for managing COVID-19.
- Further research is needed on the gut's role in SARS-CoV-2 transmission and pathogenesis.
More Related Videos
Related Concept Videos
Other Disorders of Digestive System
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...


